Please assess the completion status of the following clinical trial:

Trial Title: Tenelia Elderly CGMS Study(TEDDY)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who are 65 years or older on screening~* Patients with type 2 diabetes mellitus~* Patients with 7.0% ≤ HbA1c ≤ 9.0% at the screening visit~* Patients with FPG \< 270mg/dL on screening visit~Exclusion Criteria:~-

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Teneligliptin (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).